Bipolar affective disorder: A review of novel forms of therapy
References
- 1. Amrollahi Z. et al.: Double-blind, randomized, placebo-controlled 6-week study on the efficacy and safety of the tamoxifen adjunctive to lithium in acute bipolar mania. J. Affect. Disord., 129, 327, 2011.
- 2. Anand A. et al.: Early antidepressant effect of memantine during augmentation of lamotrigine inadequate response in bipolar depression: a double-blind, randomized, placebo-controlled trial. Bipolar Disord., 14, 64, 2012.<a href="https://doi.org/10.1111/j.1399-5618.2011.00971.x22329473" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1111/j.1399-5618.2011.00971.x22329473</a>
- 3. Berk M. et al.: Maintenance N-acetyl cysteine treatment for bipolar disorder: A double-blind randomized placebo controlled trial. Berk et al. BMC Med., 10, 91, 2012.<a href="https://doi.org/10.1186/1741-7015-10-91348258022891797" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1186/1741-7015-10-91348258022891797</a>
- 4. Berk M. et al.: The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: An open label trial. J. Affect. Disord., 135, 389, 2011.<a href="https://doi.org/10.1016/j.jad.2011.06.00521719110" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.jad.2011.06.00521719110</a>
- 5. Dell’Osso B. et al.: Superior chronic tolerability of adjunctive modafinil compared to pramipexole in treatment-resistant bipolar disorder. J. Affect. Disord., 150, 130, 2013.<a href="https://doi.org/10.1016/j.jad.2012.11.03023261131" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.jad.2012.11.03023261131</a>
- 6. Fan A. et al.: Allopurinol augmentation in the outpatient treatment of bipolar mania: a pilot study. Bipolar Disord., 14, 206, 2012.<a href="https://doi.org/10.1111/j.1399-5618.2012.01001.x22420596" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1111/j.1399-5618.2012.01001.x22420596</a>
- 7. Gao Y. et al.: Memantine reduces mania-like symptoms in animal models. Psychiatry Res., 188, 366, 2011.<a href="https://doi.org/10.1016/j.psychres.2010.12.03021269711" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.psychres.2010.12.03021269711</a>
- 8. Ionescu D.F. et al.: A single infusion of ketamine improves depression scores in patients with anxious bipolar depression. Bipolar Disord., 17(4), 438, 2015, doi: <a href="https://doi.org/10.1111/bdi.12277.10.1111/bdi.12277443195525400146" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1111/bdi.12277.10.1111/bdi.12277443195525400146</a>
- 9. Jahangard L. et al.: In a double-blind, randomized and placebocontrolled trial, adjuvant allopurinol improved symptoms of mania in in-patients suffering from bipolar disorder; Eur. Neuropsychopharmacol., 24, 1210, 2014.
- 10. Koukopoulos A. et al.: The sustained mood-stabilizing effect of memantine in the management of treatment resistant bipolar disorders: Findings from a 12-month naturalistic trial; J. Affect. Disord., 136, 163, 2012.<a href="https://doi.org/10.1016/j.jad.2011.09.04022030128" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.jad.2011.09.04022030128</a>
- 11. Kulkarnia J. et al.: A four week randomised control trial of adjunctive medroxyprogesterone and tamoxifen in women with mania; Psychoneuroendocrino., 43, 52, 2014.<a href="https://doi.org/10.1016/j.psyneuen.2014.02.00424703170" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.psyneuen.2014.02.00424703170</a>
- 12. Lally N. et al.: Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression; Transl. Psychiatry, 4, e469; doi:<a href="https://doi.org/10.1038/tp.2014.10" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1038/tp.2014.10</a>, 2014.<a href="https://doi.org/10.1038/tp.2014.10396603824643163" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1038/tp.2014.10396603824643163</a>
- 13. Magalhaes P.V. et al.: N-acetyl cysteine add-on treatment for bipolar II disorder: a subgroup analysis of a randomized placebo-controlled trial; J. Affect. Disord., 129, 317, 2011.<a href="https://doi.org/10.1016/j.jad.2010.08.00120800897" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.jad.2010.08.00120800897</a>
- 14. Nguyen T.V. et al.: Hormonal Treatments for Bipolar Disorder: A Review of the Literature; Journal of Behavioral and Brain Science, 2, 48, 2012.<a href="https://doi.org/10.4236/jbbs.2012.21006" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.4236/jbbs.2012.21006</a>
- 15. Niemegers P. et al.: Pharmacokinetic evaluation of armodafinil for the treatment of bipolar depression; Expert Opin. Drug Metab. Toxicol., 8(9), 1189, 2012.<a href="https://doi.org/10.1517/17425255.2012.70833822803602" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1517/17425255.2012.70833822803602</a>
- 16. Permoda-Osip A. et al.: Factors connected with efficacy of single ketamine infusion in bipolar depression; Psychiatr. Pol., 48, 35, 2014.<a href="https://doi.org/10.12740/PP/21175" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.12740/PP/21175</a>
- 17. Savitz J. et al.: Minocycline and aspirin in the treatment of bipolar depression: a protocol for a proof-of-concept, randomised, doubleblind, placebo-controlled, 2x2 clinical trial; BMJ Open, 2, e000643, 2011.<a href="https://doi.org/10.1136/bmjopen-2011-000643328999022357572" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1136/bmjopen-2011-000643328999022357572</a>
- 18. Sienaert P. et al.: Evidence-based treatment strategies for treatmentresistant bipolar depression: a systematic review; Bipolar Disord., 15, 61, 2013.<a href="https://doi.org/10.1111/bdi.1202623190379" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1111/bdi.1202623190379</a>
- 19. Stanley I.: Lithium and the Other Mood Stabilizers Effective in Bipolar Disorder Target the Rat Brain Arachidonic Acid Cascade; ACS Chem. Neurosci., 5, 459, 2014.<a href="https://doi.org/10.1021/cn500058v406350424786695" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1021/cn500058v406350424786695</a>
- 20. Stertz L., Magalha P.V.S., Kapczinski F.: Is bipolar disorder an inflammatory condition? The relevance of microglial activation; Curr. Opin. Psychiatry, 26,19, 2013.
- 21. Weiser M. et al.: Allopurinol for mania: a randomized trial of allopurinol versus placebo as add-on treatment to mood stabilizers and/or antipsychotic agents in manic patients with bipolar disorder; Bipolar Disord., 16, 441, 201410.1111/bdi.1220224712840
Language: English
Page range: 105 - 110
Submitted on: Mar 9, 2015
Accepted on: Apr 28, 2015
Published on: Jul 16, 2015
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Keywords:
Related subjects:
© 2015 Ewelina Dziwota, Barbara Drapala, Magdalena Gaj, Nikodem Skoczen, Marcin Olajossy, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.